Trial NCT04611243
Publication Mok C K P, Am. J. Respir. Crit., 2022
Primary outcome on the report: Humoral immunogenicity measured by sVNT, PRNT and ELISA at one month after the third dose of vaccination

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.